immune related adverse events

Immune-related adverse events are toxicities driven by immune checkpoint inhibitor-induced autoimmunity, affecting virtually every organ system. Managing these toxicities, balancing immunosuppressive treatment against cancer control, has become a subspecialty in its own right within oncology. Predictive biomarkers, risk-adapted monitoring, and treatment algorithms to optimise checkpoint inhibitor therapy continuation are active areas of development.